Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

Recent advances in molecular biology have provided unprecedented insights into the structure of amyloid fibrils associated ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

The litany of failed trials of amyloid-targeting drugs for Alzheimer's disease has added another verse, as Roche concedes that its crenezumab candidate was unable to slow cognitive decline in ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

There’s intriguing news today about a technology that could improve treatment in people with Alzheimer’s. It uses sound waves ...

Immune cells in the brain called microglia can partially break down large amyloid plaques characteristic of Alzheimer's ...

Pharmaceuticals announced that the Journal of Prevention of Alzheimer’s Disease published the results of the Phase 1 INTERCEPT-AD ...

Tolcapone is under clinical development by Corino Therapeutics and currently in Phase II for Familial Amyloid Cardiomyopathy.